BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)
Product details
Registration number: SIN13266P
Classification: General Sale List
Active ingredients:
- CALCIUM CHLORIDE (2H₂O)
- GLUCOSE MONOHYDRATE
- MAGNESIUM CHLORIDE (6H₂O)
- SODIUM CHLORIDE
- SODIUM S-LACTATE SOLUTION 50% (=SODIUM S-LACTATE )
Strength:
- 0.1838 G/L
- 25 G/L
- 0.1017 G/L
- 5.640 G/L
- 3.925 G/L
Dosage form: SOLUTION, STERILE
Route: INTRAPERITONEAL
Registrant: FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
ATC code: B05DA
HSA approval date: 2 May 2007
Manufacturer(s):
- FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
- FRESENIUS MEDICAL CARE JAPAN K.K. (BUZEN PLANT)
Manufacturing country/countries: GERMANY; JAPAN
What are the HSA registration number and classification for BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13266P
Classification: General Sale List
What active ingredients and strength are recorded for BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CALCIUM CHLORIDE (2H₂O)
- GLUCOSE MONOHYDRATE
- MAGNESIUM CHLORIDE (6H₂O)
- SODIUM CHLORIDE
- SODIUM S-LACTATE SOLUTION 50% (=SODIUM S-LACTATE )
Strength:
- 0.1838 G/L
- 25 G/L
- 0.1017 G/L
- 5.640 G/L
- 3.925 G/L
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION, STERILE
Route: INTRAPERITONEAL
Who is the recorded registrant for BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION)?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
- FRESENIUS MEDICAL CARE JAPAN K.K. (BUZEN PLANT)
Manufacturing country/countries: GERMANY; JAPAN
Where can I look up BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION) in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13266P or the exact product name BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION). The general register link does not preselect this product.
What are the source dates for this BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION) record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BALANCE 2.3% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 19 FORMULATION) record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13266P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)